Clinical Trials in Dallas

Showing 2101-2120 of 15,003 trials

Veterans Coordinated Community Care (3C) Study

NCT05272176

Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related behaviors (including deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts) and suicidal ideation and functioning.

Suicide

Brown University850 participantsStarted Jan 2022

Little Rock, Arkansas, United States • Boston, Massachusetts, United States • Minneapolis, Minnesota, United States +4 more locations

Active Not RecruitingPhase 2< 1 mile

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

NCT06577090

This is a proof-of-concept study to assess the safety and efficacy of Nimacimab Injection compared to an active and placebo injection control.

Obesity

Skye Bioscience, Inc.136 participantsStarted Aug 2024

Anniston, Alabama, United States • Walnut Creek, California, United States • Waterbury, Connecticut, United States +13 more locations

Veterans Coordinated Community Care (3C) Study

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Find Trials by Condition in Dallas

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

A Study in Patients With Mixed Dyslipidemia

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Artificial Urinary Sphincter Clinical Outcomes

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Cerliponase Alfa Observational Study in the US

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma